Lidan Zeng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lidan Zeng

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025

Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic StrategyOlena Odnokoz, Anupam Banerjee, Xin Cui, et al.

The Journal of Clinical Investigation|March 26, 2024

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancersYueming Zhu, Anupam Banerjee, Ping Xie, et al.

Nature Communications|April 14, 2025

MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025

Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic StrategyOlena Odnokoz, Anupam Banerjee, Xin Cui, et al.

The Journal of Clinical Investigation|March 26, 2024

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancersYueming Zhu, Anupam Banerjee, Ping Xie, et al.

Nature Communications|April 14, 2025

MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.

Pageof 2